Creating a Health Utility value for Birdshot Chorioretinopathy
- Type of funding: Fight for Sight / Birdshot Uveitis Society Small Grant Award
- Grant Holder: Professor Philip Murray
- Institute: University Hospitals Birmingham NHS Foundation Trust
- Region: West Midlands
- Start date: March 2018
- End Date: August 2019
- Priority: Quality of Life
- Eye Category: Ocular inflammatory
Birdshot Chorioretinopathy (BCR) is a potentially blinding condition which affects an estimated 400-500 people in the UK. There is currently very limited research on the quality of life experienced by those with birdshot Chorioretinopathy.
Health utility values are widely used in medical research, to measure the impact of a condition on the quality of life for patients. Questions are combined with other measurements in order to help form a picture of a patient’s estimate of their overall health state or ‘health utility value’.
Ms Helen Southworth from the University Hospitals Birmingham NHS Foundation Trust, will be calculating these ‘health utility values’ for Birdshot Chorioretinopathy. This has not been done previously.
Patients will be recruited into the study from the birdshot clinics at Queen Elizabeth Hospital, Birmingham. They will be asked to complete several questionnaires. The combination of their answers and their test results will be analysed to look for associations between the questionnaires’ results and the results of clinical tests.
By identifying the effect Birdshot Chorioretinopathy has on patients’ quality of life, it would help with the rethinking of how we manage patients.